Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.

Biochemistry - 8 Nov 2005

Fleck Beth A, Chen Chen, Yang Weidong, Huntley Rajesh, Markison Stacy, Nickolls Sarah A, Foster Alan C, Hoare Sam R J

Abstract excerpt

The melanocortin-4 (MC4) receptor is a potential therapeutic target for obesity and cachexia, for which nonpeptide agonists and antagonists are being developed, respectively. The aim of this study was to identify molecular interactions between the MC4 receptor and nonpeptide ligands, and to compare the mechanism of binding between agonist and antagonist ligands. Nonpeptide ligand interaction was affected by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-MSH
Share to Binding Sites
Share to Cyclic AMP

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ligands

Share to Molecular Structure

Share to Protein Structure, Secondary

Share to Protein Structure, Tertiary

Share to Receptor, Melanocortin, Type 4

Source

Identifiers

PMID: 16262250
DOI: 10.1021/bi051316s

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor.PMID 16262250Read ↗

Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation.Semantic proximity Read ↗

Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand binding.Semantic proximity Read ↗

The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.Semantic proximity Read ↗

Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients.Semantic proximity Read ↗

Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.Semantic proximity Read ↗

Classical and atypical agonists activate M1 muscarinic acetylcholine receptors through common mechanisms.Semantic proximity Read ↗

Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor.Semantic proximity Read ↗

Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.Semantic proximity Read ↗

Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs).Semantic proximity Read ↗

Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties.Semantic proximity Read ↗

A peptide display system identifies a potent mutant β-melanocyte-stimulating hormone agonist of melanocortin-4 receptor.Semantic proximity Read ↗

Pharmacological characterization of canine melancortin-4 receptor and its natural variant V213F.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.